Humatech Aktie

Humatech Forward P/E

Forward P/E-tal för Humatech (HUMT) per 15 aug. 2026 är −0,79.

Forward P/E

−0,79

Senast uppdaterad:

Forward P/E-tal för Humatech är 2026 −0,79 . Forward P/E-tal för Humatech var 2025 - . Det minskar därmed med % lägre jämfört med året innan.
Access this data via the Eulerpool API

Humatech Aktieanalys

Vad gör Humatech? Humatech Inc is an international company that specializes in the development, production, and marketing of products for the healthcare industry. The company was founded in 1983 and has since adapted its business models and strategies to meet the changing demands of the market. It is now headquartered in Virginia, USA and operates on multiple continents. The business model of Humatech Inc focuses on the manufacturing of diagnostic and testing products for laboratory and clinical facilities. These products are designed for the diagnosis of diseases such as cancer, diabetes, pregnancy, thyroid problems, and many others. The company also offers HIV, hepatitis, and troponin tests. The high quality of these products has helped the company establish strong brand recognition and customer loyalty. In addition to its products, Humatech Inc also provides services in various areas to offer comprehensive solutions tailored to individual needs. These services include consulting, software solutions, and training, contributing to optimized and efficient operations in medical facilities and laboratories. The different divisions of Humatech Inc encompass a wide range of products and services. The category of diagnostic and testing products forms the core of the company, including tests for diabetes, pregnancy, thyroid problems, cancer, HIV, and hepatitis. The range also includes specialized tests for kidney problems and heart diseases. The company is constantly striving to expand its range of tests for new health issues. Under the category of consulting services, Humatech Inc offers in-depth knowledge of current medical developments, diagnostic procedures, and testing methods. Customers can choose from a wide range of services, including the development of specific test procedures, marketing support, and workflow optimization. The "software solutions" business field includes a variety of online tools to support diagnostic procedures and tests. The software allows medical facilities and laboratories to automate their workflow, manage and analyze data, and quickly retrieve test results. To provide customers with added value, Humatech Inc also offers a range of training programs. These not only cover the operation and application of the products, but also teach optimal work and result processes. Overall, Humatech Inc is an important player in the healthcare industry. By focusing on the development and marketing of diagnostic and testing products, the company is able to sustainably convince its customers through high product quality and services. The wide product range, services, and extensive network of employees, consultants, and customers make the company a forward-thinking service provider. Humatech är ett av de mest populära företagen på Eulerpool.

Vanliga frågor om Humatech-aktien

Forward P/E-tal för Humatech är −0,79 år 2026.

På Eulerpool kan du hitta den fullständiga historiska utvecklingen av Forward P/E-tal Humatech sedan 2006 – med årliga värden, diagram och detaljerad analys.

Forward P/E använder beräknad framtida vinst för att värdera en aktie. Ett lägre forward P/E jämfört med historiskt P/E tyder på att analytiker förväntar sig vinsttillväxt.

För att utvärdera Forward P/E-tals är det viktigt att jämföra det med företag inom samma bransch och sektor. På Eulerpool kan du hitta direkta branschjämförelser för Forward P/E-tal.

Ett 'bra' värde för varierar beroende på bransch och företagets utvecklingsfas. På Eulerpool kan du jämföra Forward P/E-tals Humatech med bransckamrater och branschgenomsnittet för att bedöma om det är attraktivt.

Access this data via the Eulerpool API

Värdering — Humatech

Alla nyckeltal — Humatech